Back
Apellis Pharmaceuticals Vs. Nike Industry Stock Comparison
Sell
37
APLS
Apellis Pharmaceuticals
Last Price:
$19.92
Seasonality Move:
-18.71%
Buy
52
NKE
Nike
Last Price:
$72.28
Seasonality Move:
5%
Sell
37
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.91. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 62.08 | Buy |
Chaikin Money Flow: | -28803 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.69 - 19.29) | Buy |
Bollinger Bands (100): | (17.12 - 23.86) | Sell |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 18.05 | Buy |
Relative Strength Index (14 RSI): | 60.61 | Buy |
Chaikin Money Flow: | 6537400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.66 - 73.3) | Buy |
Bollinger Bands (100): | (57.42 - 73.28) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.69 | Buy |
20-day SMA: | 18.27 | Buy |
50-day SMA: | 18.25 | Buy |
200-day SMA: | 25.34 | Sell |
8-day EMA: | 18.95 | Buy |
20-day EMA: | 18.53 | Buy |
50-day EMA: | 18.87 | Buy |
200-day EMA: | 25.77 | Sell |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.54 | Sell |
20-day SMA: | 68 | Buy |
50-day SMA: | 63.89 | Buy |
200-day SMA: | 71.39 | Buy |
8-day EMA: | 52.34 | Buy |
20-day EMA: | 28.86 | Buy |
50-day EMA: | 13.3 | Buy |
200-day EMA: | 3.58 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.22 per share, and an increase next year of $0.74 per share.
Nike Earnings Growth & NKE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.22 per share, a decrease this year of $1.58 per share, and a decrease next year of $0.46 per share.
Apellis Pharmaceuticals Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |